Skip to content

Clinical trials

Phase 2 Inflammation trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Country / region: Norway Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20161
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3
Completed2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Akershus3
Oslo University Hospital2
University Hospital, Aker1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation6
Atherosclerosis2
Acute Coronary Syndrome1
Brain Diseases1
Central Nervous System Diseases1
Cognition Disorders1
Cognitive Dysfunction1
Coronary Disease1
Dementia1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.